Related Experiment Video
Updated: Jun 10, 2026

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
Published on: April 7, 2015
Research progress on the association between viruses and cardiac diseases
He-Min Yu1,2, Ming-Liang Zhu1, Yan-Li Zhao3
1School of Pharmaceutical Science and Yunnan Key Laboratory of Pharmacology for Natural Products, Kunming Medical University, Kunming, Yunnan, China.
Viral infections cause diverse heart diseases through direct damage and immune responses. Management involves antivirals, immunomodulation, and supportive care, with prevention crucial for reducing cardiovascular risks.
Area of Science:
- Cardiology
- Infectious Diseases
- Immunology
Background:
- Virus-related cardiac diseases are a significant cause of cardiovascular pathology.
- Viruses like SARS-CoV-2, influenza, HIV, and arboviruses can directly infect heart cells or trigger immune responses.
- These infections lead to conditions such as myocarditis, arrhythmias, and heart failure.
Purpose of the Study:
- To review the diverse spectrum of virus-related cardiac diseases.
- To elucidate the multifactorial mechanisms of cardiac involvement by viruses.
- To outline current and future therapeutic and preventive strategies.
Main Methods:
- Comprehensive literature review of cardiotropic and cardioactive viruses.
- Analysis of mechanisms including direct viral cytopathic effects, immune-mediated injury, and systemic effects.
- Synthesis of clinical manifestations, therapeutic approaches, and preventive measures.
Main Results:
- Viral infections contribute to myocardial injury through direct infection, immune activation, inflammation, fibrosis, and endothelial dysfunction.
- Clinical presentations vary from subclinical injury to severe heart failure and long-term sequelae like in long COVID.
- Effective management requires early antiviral therapy, tailored immunomodulation, and supportive care for cardiac dysfunction.
Conclusions:
- Integrated strategies encompassing prevention, acute management, and long-term care are essential.
- Optimizing diagnostics, understanding mechanisms, and conducting clinical trials are critical for future advancements.
- Vaccination, protective measures, and cardiovascular risk factor management are key preventive strategies.
Related Concept Videos
Myocarditis III: Medical Management
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Cardiomyopathy I: Introduction and Classification
Myocarditis I: Introduction
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Coronary Artery Disease II: Pathophysiology
